Principal investigator Jason Luke, MD, discusses what the new data means for melanoma treatment moving forward.
Jason Luke, MD, FACP
Advertisement
Articles by Jason Luke, MD, FACP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Dermatology Times
1
ORKA-001 Achieves 61% Complete Skin Clearance in Psoriasis
2
How Approvals, Setbacks, and a Crowded Pipeline Are Reshaping the AD Treatment Landscape
3
FDA Revises TB Evaluation Guidance for SKYRIZI
4
Avoiding Common Mistakes When Escalating Therapy in Psoriasis
5